Pharmacological blockade of selective amino acid transporters in diabetes may limit availability of amino acids in the kidneys for protein synthesis/metabolism, thereby offering a potential avenue for the prevention and treatment of DN. The gene discussed is SLC38A7; the disease is diabetes mellitus.